Should cholinesterase inhibitors be used to treat Alzheimer's disease?

Thomas Finucane, John R. Gilstad

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)118-119
Number of pages2
JournalNature Clinical Practice Neurology
Volume2
Issue number3
DOIs
StatePublished - Mar 2006

Fingerprint

Cholinesterase Inhibitors
Psychometrics
Alzheimer Disease
Quality of Life
Clinical Trials

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Should cholinesterase inhibitors be used to treat Alzheimer's disease? / Finucane, Thomas; Gilstad, John R.

In: Nature Clinical Practice Neurology, Vol. 2, No. 3, 03.2006, p. 118-119.

Research output: Contribution to journalArticle

@article{ca9e21a168b147f586c407af04e4bb86,
title = "Should cholinesterase inhibitors be used to treat Alzheimer's disease?",
author = "Thomas Finucane and Gilstad, {John R.}",
year = "2006",
month = "3",
doi = "10.1038/ncpneuro0130",
language = "English (US)",
volume = "2",
pages = "118--119",
journal = "Nature Reviews Neurology",
issn = "1759-4758",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Should cholinesterase inhibitors be used to treat Alzheimer's disease?

AU - Finucane, Thomas

AU - Gilstad, John R.

PY - 2006/3

Y1 - 2006/3

UR - http://www.scopus.com/inward/record.url?scp=33644590895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644590895&partnerID=8YFLogxK

U2 - 10.1038/ncpneuro0130

DO - 10.1038/ncpneuro0130

M3 - Article

C2 - 16932534

AN - SCOPUS:33644590895

VL - 2

SP - 118

EP - 119

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

IS - 3

ER -